CEL-SCI CORPORATION (CVM) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $173.08K; Additional Paid in CapitalUSD $566.81M; Retained Earnings (Accumulated Deficit)USD $-556.03M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $82.12K; Additional Paid in CapitalUSD $557.15M; Retained Earnings (Accumulated Deficit)USD $-550.36M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $80.55K; Additional Paid in CapitalUSD $555.95M; Retained Earnings (Accumulated Deficit)USD $-544.89M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $80.16K; Additional Paid in CapitalUSD $555.30M; Retained Earnings (Accumulated Deficit)USD $-539.42M.
CEL-SCI CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $173.08K | $566.81M | $-556.03M | $10.96M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $82.12K | $557.15M | $-550.36M | $6.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $80.55K | $555.95M | $-544.89M | $11.14M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $80.16K | $555.30M | $-539.42M | $15.96M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $53.21K | $540.29M | $-533.32M | $7.02M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $843.50K | $534.81M | $-527.66M | $8.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $730.84K | $531.66M | $-521.08M | $11.31M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $21.27K | $526.86M | $-514.01M | $12.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $542.58K | $515.83M | $-507.90M | $8.47M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $540.84K | $514.81M | $-501.05M | $14.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $500.19K | $505.95M | $-493.80M | $12.65M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $474.22K | $499.83M | $-487.09M | $13.21M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $447.48K | $493.80M | $-479.46M | $14.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $437.88K | $490.80M | $-471.09M | $20.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $437.26K | $488.90M | $-462.75M | $26.59M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $434.48K | $486.63M | $-454.90M | $32.16M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $433.56K | $484.73M | $-446.44M | $38.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $433.05K | $481.50M | $-436.80M | $45.13M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $432.59K | $477.90M | $-426.98M | $51.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-10-01 | (m) | (m) | (m) | (m) | $56.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $432.07K | $474.30M | $-418.20M | $56.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $429.63K | $469.36M | $-409.99M | $59.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $408.24K | $429.98M | $-401.05M | $29.33M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $397.67K | $418.21M | $-389.77M | $28.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-10-01 | (m) | (m) | (m) | (m) | $19.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $387.30K | $401.17M | $-381.84M | $19.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $385.22K | $396.96M | $-376.46M | $20.89M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $373.37K | $379.94M | $-366.18M | $14.14M | (m) | 3 month · $199.37K | (m) | 3 month · $1.78M | (m) | (m) |
| 2019-12-31 | $0.00 | $359.95K | $365.71M | $-357.11M | $8.95M | (m) | 3 month · $92.15K | (m) | 3 month · $1.80M | (m) | (m) |
| 2019-09-30 | $0.00 | $352.32K | $358.51M | $-353.73M | $5.13M | (m) | 12 month · $-132.34K | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $340.67K | $349.68M | $-348.88M | $1.15M | (m) | 3 month · $8.01K | (m) | 3 month · $1.52M | (m) | (m) |
| 2019-03-31 | $0.00 | $299.52K | $337.45M | $-336.79M | $955.52K | (m) | 3 month · $43.62K | (m) | 3 month · $530.83K | (m) | (m) |
| 2018-12-31 | $0.00 | $278.44K | $332.78M | $-330.35M | $2.71M | (m) | (m) | (m) | 3 month · $573.66K | (m) | (m) |
| 2018-09-30 | $0.00 | $280.35K | $331.31M | $-331.59M | $916.00 | (m) | 12 month · $-206.58K | (m) | 12 month · $2.74M | (m) | (m) |
| 2018-06-30 | $0.00 | $195.71K | $315.22M | $-316.66M | $-1.25M | (m) | (m) | (m) | 3 month · $465.49K | 3 month · $291.23K | (m) |
| 2018-03-31 | $0.00 | $166.25K | $307.43M | $-310.65M | $-3.06M | (m) | 3 month · $94.77K | (m) | 3 month · $279.82K | (m) | (m) |
| 2017-12-31 | $0.00 | $132.58K | $300.98M | $-305.94M | $-4.83M | (m) | (m) | (m) | 3 month · $1.45M | (m) | (m) |
| 2017-09-30 | $0.00 | $119.03K | $296.30M | $-299.75M | $-3.34M | (m) | (m) | (m) | 12 month · $1.48M | (m) | 12 month · $-4.67M |
| 2017-06-30 | $0.00 | $92.19K | $289.58M | $-294.76M | $-5.08M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $0.00 | $86.56K | $287.38M | $-290.30M | $-2.83M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $76.34K | $286.49M | $-281.87M | $4.69M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $0.00 | $62.48K | $284.65M | $-285.39M | $-679.21K | $-679.21K | (m) | (m) | 12 month · $2.01M | (m) | 12 month · $-8.72M |
| 2016-06-30 | $0.00 | $1.45M | $279.33M | $-284.55M | $-3.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $0.00 | $1.35M | $276.42M | $-280.70M | $-2.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $1.30M | $274.09M | $-271.86M | $3.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $0.00 | $44.91K | $269.07M | $-273.88M | $-4.76M | $-4.76M | (m) | (m) | 12 month · $5.11M | (m) | 12 month · $-8.46M |
| 2015-06-30 | $0.00 | $1.12M | $267.16M | $-264.36M | $3.93M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $915.49K | $259.36M | $-259.93M | $343.06K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $0.00 | $914.83K | $258.30M | $-247.37M | $11.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $0.00 | $819.02K | $249.15M | $-239.19M | $10.78M | $10.78M | (m) | (m) | 12 month · $3.96M | (m) | 12 month · $-7.79M |
| 2014-06-30 | $0.00 | $660.42K | $246.68M | $-232.31M | $15.04M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $0.00 | $582.77K | $236.63M | $-229.86M | $7.36M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $0.00 | $558.53K | $231.05M | $-216.49M | $15.11M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $0.00 | $310.25K | $218.55M | $-211.83M | $6.70M | $6.70M | (m) | 12 month · $2.64M | 12 month · $2.64M | 12 month · $0.00 | 12 month · $-4.20M |
| 2013-06-30 | $0.00 | $3.10M | $215.16M | $-210.46M | $7.80M | (m) | (m) | (m) | (m) | 9 month · $0.00 | 9 month · $0.00 |
| 2013-03-31 | $0.00 | $3.09M | $214.47M | $-206.01M | $11.55M | (m) | (m) | (m) | (m) | 6 month · $0.00 | 6 month · $0.00 |
| 2012-12-31 | $0.00 | $3.09M | $213.83M | $-205.30M | $11.62M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $0.00 | $273.12K | $209.74M | $-202.99M | $7.03M | (m) | (m) | 12 month · $2.23M | (m) | 12 month · $-1.59M | 12 month · $-122.37K |
| 2012-06-30 | $0.00 | $2.73M | $206.71M | $-200.42M | $9.01M | (m) | (m) | (m) | (m) | 9 month · $-1.59M | 9 month · $-122.37K |
| 2012-03-31 | $0.00 | $2.57M | $203.26M | $-199.59M | $6.24M | (m) | (m) | (m) | (m) | 6 month · $-1.59M | 6 month · $-122.37K |
| 2011-12-31 | $0.00 | $2.30M | $196.91M | $-191.09M | $8.11M | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 |
| 2011-09-30 | $0.00 | $2.15M | $194.44M | $-187.51M | $9.08M | (m) | (m) | (m) | (m) | 12 month · $0.00 | 12 month · $-202.83K |
| 2011-06-30 | $0.00 | $2.11M | $192.27M | $-185.19M | $9.18M | (m) | (m) | (m) | (m) | 9 month · $-1.07M | 9 month · $-202.83K |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-202.83K |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-61.62K |
| 2010-09-30 | $0.00 | $2.05M | $187.61M | $-161.80M | $27.85M | (m) | (m) | (m) | (m) | 12 month · $-1.53M | 12 month · $-5.51M |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-1.43M | 9 month · $-5.51M |
| 2009-09-30 | (m) | (m) | (m) | (m) | $8.84M | (m) | (m) | (m) | (m) | 12 month · $-24.06K | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | $10.84M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |